他汀类药物调脂外的作用
被引量:2
Non lipid-lowering effect of statins
摘要
多项试验显示,他汀类药物的有益作用不仅仅在于降低胆固醇,还在于其具有一些非调脂作用。
出处
《药品评价》
CAS
2011年第9期42-46,共5页
Drug Evaluation
参考文献20
-
1Gelosa P,Cimino M,Pignieri A,et al.The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation[J].Vasc Health Risk Management,2007,3(5):567-577.
-
2Takemoto M,Sun J,Hiroki J,et al.Rho-kinase mediates hypoxia-induced down regulation of endothelial nitric oxide synthase[J].Circulation,2002,106(1):57-62.
-
3Davignon J.Beneficial cardiovascular pleiotropic effects of statins[J].Circulation,2004,109:Ⅲ39-Ⅲ43.
-
4Schneider DB,Vassolli G.Expression of Fas Ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lension formation[J].Arterioscler Thromb Vasc Biol,2000,20(2):298-308.
-
5黄全跃,赵水平.他汀类药物的抗血栓作用[J].医学临床研究,2004,21(1):12-14. 被引量:35
-
6范伯丽,程颖,房家智,蒋宝琦,GNeil Thomas,Julian AJH Critchley,Brian Tomlinson.阿托伐他汀对高脂血症患者血小板聚集反应的影响[J].中国动脉硬化杂志,2003,11(5):455-458. 被引量:12
-
7Akdim F,Kastelein JJ,Stroes ES.Pleiotropic effects of statins:stabilization of the vulnerable atherosclerotic plaque[J] ? Curr Pharmaceutical Design,2007,13(10):1003-1012.
-
8Chiu JH,Abdelhadi RH,Chung MK,et al.Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator[J].Am J Cardiol,20o5,95:490-491.
-
9Pietsch A,Erl W,Lorenz RL.Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells[J].Biochem Pharmacol,1996,52:433-439.
-
10Bellosta S,Via D,Canavesi M.HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages[J].Arterioscler Thromb Vasc Biol,1998,18:1671-1678.
二级参考文献52
-
1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
-
2Zhang x, pateI A, Horibe H, et al. cholesterol, coronry heart disease, and stmlte in the AsiaPacific region. Int J pidenliol, 2003,32: 563 -572.
-
3Executivesummawof the Third RePOEt ofthe National cholesteml Education pmeanl (NCEP) ExpenPanel on Detection, Evaluation, and Treatment d Hid1 Blood cholesterol in Adults( Adult Treatment PanelE) Exped Panel on Detection, Evaluation, and Treatment d Hidl Blood cholesteml in Adults. JAMA,2001,285 : 2486-2497.
-
4Baigent C, keech A, Keanl ey PM, et al. EEicacy and safety of cholestemllowering treatment : prospective meta-analysisof data fmn190, 056panicipmts in 14randomised trialsof statins-Lancet, 2005,366 : 1267-1278.
-
5Di NaPoli P, Tacei AA, Oliver M, et al. Statm and stroke : evidence for cddIhhl modlk, independent efteds-Eur Head J, 2002, 23: 1908-1921.
-
6Amarenco p, Labmuche J, LavallP, et al. Stains in smdte prevention and camtidatherosclemsis : systematic IView and up-to-date meta-analysis-Stmlte, 2004,35 : 2902-2909.
-
7Cannon CP, Steinberg BA, M1111311 y SA, et al. Meta-analysis d cardiovascular outcomes tdalscompadng intensive veI311 s moderate staun therapy. J Am COIl Cardiol ,2006,48:438-445.
-
8Colhoun HM, Betteridge D J, Duntneon-PN, et al. Primary prevention d caMiovascular diseasewith atOIYastain in type2 diabetes in the COIlabomtive AtOIVastatin Diabetes Study ( CARDS ) : mulucentre randomised placebo-controlled Mal. Lancet ,2004,364:685-696.
-
9Eumpean Stmlte Organisation(ESO) Executive Committe;ESO Writing Committee. Guidelinesfor management of ischaemic stmite and transient ischaemic attack 2008. CerebI, vase Dis, 2008, 25: 457 -507.
-
10Codellaro M, cofrancescoE, AEustini E, et aL Atowastain and thmmbogenicity d the carotidatheroselemtplaque:the ATROCAP study- Thmmb Haemost,2002 ,88 :41-47.
共引文献63
-
1罗远琼,糜漫天,张乾勇,韦娜,余小平.洛伐他汀对BRCA1高表达MCF-7乳腺癌细胞周期调控蛋白的影响[J].第三军医大学学报,2004,26(12):1061-1064. 被引量:2
-
2陈运中,陈春艳,张声华.红曲红色素组分Ⅰ对实验小鼠脂质代谢的影响[J].食品科学,2004,25(8):164-168. 被引量:3
-
3张明,姜达.他汀类药物在抗肿瘤中的研究进展[J].肿瘤防治研究,2004,31(11):714-717. 被引量:6
-
4李勇.论企业发展与提高竞争力[J].塑料包装,2005,15(1):48-50.
-
5赵东.他汀类药物的药理作用及临床研究近况[J].天津药学,2004,16(6):61-64. 被引量:4
-
6曲迅,郑广娟,刘德山,杨美香,冯进波,闫实.体外罗勒多糖抗人高转移肺癌细胞侵袭转移作用及机制探讨[J].中国病理生理杂志,2005,21(7):1345-1348. 被引量:18
-
7黄赛杰.他汀类药物的非降脂作用[J].医药导报,2006,25(1):25-27. 被引量:5
-
8黄全跃,赵水平,吴洪光,周宏年,李江,罗小岚.不同剂量辛伐他汀对急性冠状动脉综合征患者组织因子和组织因子途径抑制物的影响[J].中国动脉硬化杂志,2005,13(5):633-635. 被引量:11
-
9黄萍,蒙华.他汀类药物的非降脂作用应用评价[J].中国医院用药评价与分析,2006,6(1):17-21. 被引量:7
-
10孙姗,吴尚勤.阿托伐他汀非调脂作用的最新进展[J].中国临床药理学与治疗学,2006,11(2):141-144. 被引量:30
同被引文献49
-
1叶平.2012他汀类药物安全性再认识[J].中国医学前沿杂志(电子版),2012,4(8):1-4. 被引量:13
-
2李建军.如何认识调脂药物的调脂外作用[J].中国医学前沿杂志(电子版),2012,4(8):11-13. 被引量:6
-
3韩薇,李为民.他汀类药物独立于降脂作用以外的多效性评价[J].中华老年医学杂志,2005,24(11):875-877. 被引量:2
-
4杨诗杰,苏汝好,项岚,乔海灵.降血脂药的应用现状及研究进展[J].医药论坛杂志,2006,27(1):90-92. 被引量:31
-
5李筱雯,艾华,张宝慧,陈志民,刘晓鹏,谢岚.运动及饮食疗法对代谢综合征患者及高危者的治疗作用[J].中国康复医学杂志,2007,22(1):9-12. 被引量:13
-
6Fukumoto Y,Libby P,Rabkin E,et al.Statins alter smooth muscle cell accumulation and collagen content in established atheroma of wan- tanabe heritable hyperlipidenaic rabbits[J].Circulation ,2001,103 (7): 993 -999.
-
7Carl JV,Antonio MG,Craig TB.The evolving role of statins in the management of atherosclerosis[J].J Am Coil Cardio1,2000,35 ( 1 ) : 1-10.
-
8Kearney D,Fitzgerald D.The anti-thrombotic effects of statins[J].J Am Coll Cardiol, 1999,33(5) : 1305-1307.
-
9Cohen DE,Anania FA ,Chalasani N.For the National Lipid Association Statin Safety Task Force Liver Expert Panel.An assessment of statin safety by hepatologists[J].Am J Cardiol, 2006,97 (8A) : 77C-81C.
-
10Armitage J.The safety of statins in clinical practice [J].Lancet, 2007,370(9601 ) : 1781-1790.
引证文献2
-
1卢熠,杨悦.降血脂药物的临床应用与展望[J].中国当代医药,2014,21(5):180-182. 被引量:18
-
2梅小平,翟阳,黎军宏,邹敏,舒建龙,杨开,唐爱华.代谢综合征与血管性痴呆的研究近况[J].大众科技,2016,18(5):74-76. 被引量:1
二级引证文献19
-
1罗宇东,蒋林,刘源焕,陈洪涛.蓝参降脂片对高脂模型大鼠血脂水平的影响[J].广西中医药,2015,38(2):72-74. 被引量:4
-
2蒋芦荻,贺昱甦,陈茜,陶欧,李贡宇,张燕玲.基于分子对接技术的高频降脂药对作用机制研究[J].中国中药杂志,2015,40(12):2413-2419. 被引量:18
-
3钟禄彪,徐永敏,邓杰文,冯悦,王成,李峥,夏雪山.勃氏甜龙竹水对高血脂大鼠降血脂作用及脂代谢相关基因表达的影响[J].天然产物研究与开发,2015,27(8):1396-1401. 被引量:3
-
4褚小琴,闫少杰,张远,李树军,王平保.新型降脂药物bempedoic acid[J].现代药物与临床,2015,30(11):1417-1421. 被引量:1
-
5罗宇东,蒋林,朱智德,陈洪涛.六味葛蓝降脂片大鼠30d喂养试验研究[J].中国当代医药,2016,23(9):15-18. 被引量:4
-
6朱智德,蒋林,罗宇东,陈洪涛.六味葛蓝降脂片对小鼠急性经口毒性及遗传毒性的试验研究[J].中国当代医药,2016,23(12):4-7. 被引量:6
-
7农毅清,蒋林,罗宇东,蒙初曦.六味葛蓝降脂片质量标准研究[J].食品与药品,2016,18(3):170-174. 被引量:4
-
8王振华,张倩,刘建平,钟理,张志辉,舒茂琴,胡厚源,迟路湘,景涛,宋治远,仝识非.依折麦布对冠心病患者血脂代谢及颈动脉斑块的影响[J].第三军医大学学报,2016,38(21):2345-2348. 被引量:15
-
9张国领.辛伐他汀致双侧踝关节水肿1例[J].中国医药导报,2017,14(3):177-179. 被引量:1
-
10秦丹,牛刚,张飘飘,宋海波,靳洪涛,李鹏.降血脂药品不良反应报告分析[J].中国药物评价,2017,34(3):189-195. 被引量:3
-
1H.Haller,徐永健.钙离子拮抗剂稳定内皮功能[J].德国医学,1994,11(4):195-195. 被引量:3
-
2魏玲,杨丽霞,齐峰,郭传明,石燕昆,赵颖,王燕.高血压患者静滴维生素C后血中NO含量的测定[J].云南医药,2002,23(4):275-276.
-
3孙宁玲,王静毅,杨沁,全劼,李辉,周永莹.复方丹参在急性心肌梗塞抗凝治疗中的有益作用[J].北京医科大学学报,1992,24(2):135-136. 被引量:9
-
4梁高永,殷献宾,王浩珍,张祖玲,刘韫,李芳,朱超,周晓东,许继侠.洛伐他汀治疗高脂血症疗效观察[J].中原医刊,2001,28(5):46-47. 被引量:1
-
5袁岩,严晓伟.他汀类药物调脂以外的作用[J].世界医学杂志,2003,7(6):55-58.
-
6刘时武,丁世芳.他汀类药物的非调脂作用[J].华南国防医学杂志,2008,22(2):63-65. 被引量:13
-
7曾祥鸿.他汀类药物的新用途[J].中国处方药,2004,3(6):37-39. 被引量:2
-
8叶平.血脂异常治疗的进展及循证医学的启示[J].中华老年心脑血管病杂志,2003,5(2):143-144. 被引量:5
-
9安丽萍,王嵬民,陈国俊.氟伐他汀对急性冠状动脉综合征患者脂联素的影响[J].中华老年心脑血管病杂志,2008,10(10):783-783. 被引量:3
-
10Dale.,JE,马骥超.降低胆固醇会致癌吗?[J].美国医学会杂志(中文版),1996,15(5):288-290.